New Drugs from Novartis and Daiichi Sankyo Will Achieve Blockbuster Status in the Hypertension Drug Market
New Drugs from Novartis and Daiichi Sankyo Will Achieve Blockbuster Status in the Hypertension Drug Market
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that new drugs from Novartis and Daiichi Sankyo will achieve blockbuster status in the drug market to treat hypertension.



